Category: Funding Roundup
NeuWave Medical raised more than $25 million in equity financing as it works to advance the market for its microwave ablation tumor removal tool.
NeuWave Medical – developer of a microwave ablation tumor removal tool – has pulled in more than $25.3 million in new equity financing.
Although it's a challenge for new medical device companies to arrange financing, there are funding opportunities out there for medtech startups willing to look beyond venture capital.
Financing for medtech startups can still be found, but the market climate is less than ideal, panelists at a LifeScience Alley conference said this week in Minneapolis.
The panel, "Financing Opportunities in Today's Marketplace," discussed venture capital, IPOs, strategic investors and the important role played by a board of directors play.
Here's a look at some of the top legal news stories for medical device companies this week: PAD: Shockwave Medical raises $40M; PAD: Intact Vascular raises $39m for Tack device; ConvaTec plans $1.9B refi; Outset Medical raises $60m for home dialysis device; Smith & Nephew gets in on OrthoSpace round
Smith & Nephew joins a funding round for Israel-based OrthoSpace and its InSpace rotator cuff-treating balloon system.
Home hemodialysis device developer Outset Medical raises $60 million for its Tablo dialysis system.
Shockwave Medical says it raised $40 million for its 'lithoplasty' system to treat peripheral artery disease.
Shockwave Medical announced $40 million in funding for its novel balloon catheter designed to treat calcified lesions in the peripheral vasculature.
ConvaTec, with a new CEO at the helm, plans to raise nearly $1.9 billion in loan and credit facilities in a bid to refinance its debt.
ConvaTec, which just named a new CEO and is rumored to be up for sale, plans to raise nearly $1.9 billion in loan and credit facilities in a debt-refinancing move.